Crossmark

Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer

Crossref DOI link: https://doi.org/10.1007/s10549-017-4633-6

Published Online: 2018-01-05

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Asaduzzaman, Muhammad

Constantinou, Stephanie

Min, Haoxiang

Gallon, John

Lin, Meng-Lay

Singh, Poonam

Raguz, Selina

Ali, Simak

Shousha, Sami

Charles Coombes, R.

Lam, Eric W.-F.

Hu, Yunhui

Yagüe, Ernesto https://orcid.org/0000-0003-2371-0032
License Information

License valid from 2018-01-01